Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
New Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives Inhibit FAK Phosphorylation and Potentiate the Antiproliferative Effects of Gemcitabine Through Modulation of the Human Equilibrative Nucleoside Transporter-1 in Peritoneal Mesothelioma.
Li Petri G, Pecoraro C, Randazzo O, Zoppi S, Cascioferro SM, Parrino B, Carbone D, El Hassouni B, Cavazzoni A, Zaffaroni N, Cirrincione G, Diana P, Peters GJ, Giovannetti E. Li Petri G, et al. Among authors: randazzo o. Anticancer Res. 2020 Sep;40(9):4913-4919. doi: 10.21873/anticanres.14494. Anticancer Res. 2020. PMID: 32878779
"Open Sesame?": Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer.
Randazzo O, Papini F, Mantini G, Gregori A, Parrino B, Liu DSK, Cascioferro S, Carbone D, Peters GJ, Frampton AE, Garajova I, Giovannetti E. Randazzo O, et al. Cancers (Basel). 2020 Oct 31;12(11):3206. doi: 10.3390/cancers12113206. Cancers (Basel). 2020. PMID: 33142664 Free PMC article.